Arrowhead Pharmaceuticals Inc. buy Morgan Stanley
Start price
21.04.26
/
50%
€61.38
Target price
21.04.27
€84.90
Performance (%)
22.61%
Price
16:00
€75.26
Summary
This prediction is currently active. The BUY prediction by Morgan_Stanley currently has a performance of 22.61%. This prediction currently runs until 21.04.27. The prediction end date can be changed by Morgan_Stanley at any time. Morgan_Stanley has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Arrowhead Pharmaceuticals Inc. | 0.916% | 0.916% |
| iShares Core DAX® | -1,59 % | 5,03 % |
| iShares Nasdaq 100 | -4,15 % | -0,13 % |
| iShares Nikkei 225® | -6,30 % | 0,53 % |
| iShares S&P 500 | -3,23 % | 0,47 % |
Comments by Morgan_Stanley for this prediction
In the thread Arrowhead Pharmaceuticals Inc. diskutieren
Arrowhead Pharmaceuticals (ARWR) was upgraded by Morgan Stanley from "equal weight" to "overweight". They now have a $100.00 price target on the stock, up from $78.00.
Ratings data for ARWR provided by MarketBeat
Stopped prediction by Morgan_Stanley for Arrowhead Pharmaceuticals Inc.
Arrowhead Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€76.32
23.07.26
23.07.26
€105.00
23.07.27
23.07.27
-1.39%
16:00
16:00
